RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
<p>Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significa...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Столичная издательская компания,
2015-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p>Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-group differences. Ramipril is the one of the most studied drug of this group recommended for patients after acute myocardial infarction.</p> |
|---|---|
| Item Description: | 1819-6446 2225-3653 10.1234/1819-6446-2007-4-58-60 |